Prelude TherapeuticsPRLD
13F holders, Q2 2024 (June 30)61holders +3
8new positions
7sold out
2famous investors
$3.81avg. 13F price*
At the end of Q2 2024, 61 institutions reported holding Prelude Therapeutics Inc. (PRLD) in their 13F filings, up 3 from Q1 2024. 8 opened new positions and 7 sold out. The largest holders were Orbimed Advisors LLC ($41.6M), Baker Bros. Advisors LP ($38.6M) and Deerfield Management Company, L.P. ($15.7M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Prelude Therapeutics Inc.
- CUSIP
- 74065P101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $221K |
| Exits | 7 | $960K |
All 13F filers, Q1 2024 → Q2 2024: 117,925 shares bought and 427,793 shares sold, net −309,868 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 61 holders
| Orbimed Advisors LLC | 0.83% | No change | 10,909,256 | $41.6M |
| Baker Bros. Advisors LP | 0.50% | No change | 10,123,824 | $38.6M |
| Deerfield Management Company, L.P. | 0.30% | No change | 4,133,000 | $15.7M |
| Boxer Capital, LLC | 0.52% | No change | 2,568,287 | $9.8M |
| BlackRock Inc. | 0.00% | Reduce -2.6% | 1,068,916 | $4.1M |
| Vanguard Group Inc. | 0.00% | Reduce -0.6% | 1,010,565 | $3.9M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -5.4% | 891,298 | $3.4M |
| Massachusetts Financial Services Co. | 0.00% | Add +2.8% | 522,375 | $2.0M |
| Geode Capital Management, LLC | 0.00% | Add +0.1% | 361,951 | $1.4M |
| Sio Capital Management, LLC | 0.46% | No change | 320,394 | $1.2M |
| Morgan Stanley | 0.00% | Reduce -3.0% | 287,354 | $1.1M |
| State Street Corp. | 0.00% | Add +0.1% | 211,746 | $807K |
| Renaissance Technologies | 0.00% | Reduce -15.6% | 206,600 | $787K |
| TD Asset Management Inc | 0.00% | No change | 160,652 | $612K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +0.5% | 128,033 | $488K |
| Northern Trust Corp. | 0.00% | Add +2.1% | 124,686 | $475K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 123,600 | $471K |
| Goldman Sachs Group Inc. | 0.00% | Add +11.1% | 74,923 | $285K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -3.1% | 70,045 | $267K |
| Two Sigma Advisers, LP | 0.00% | Reduce -27.5% | 50,900 | $194K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -23.7% | 48,727 | $186K |
| Two Sigma Investments, LP | 0.00% | Reduce -28.8% | 43,135 | $164K |
| Bank of New York Mellon Corp | 0.00% | Reduce -9.5% | 36,276 | $138K |
| Kennedy Capital Management LLC | 0.00% | Add +40.9% | 35,283 | $134K |
| Bank of America Corp. | 0.00% | Add +6.2% | 34,278 | $131K |
| Citadel Advisors | 0.00% | Add +5.3% | 31,388 | $120K |
| Dimensional Fund Advisors LP | 0.00% | Add +103.2% | 29,074 | $111K |
| HSBC Holdings PLC | 0.00% | No change | 24,905 | $91K |
| Acadian Asset Management LLC | 0.00% | No change | 22,110 | $83K |
| Rhumbline Advisers | 0.00% | Add +1.9% | 21,565 | $82K |
| New York State Common Retirement Fund | 0.00% | Reduce -5.0% | 19,122 | $73K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 18,839 | $72K |
| State of Wisconsin Investment Board | 0.00% | Reduce -4.6% | 18,700 | $71K |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 17,761 | $68K |
| Nuveen Asset Management, LLC | 0.00% | No change | 16,797 | $64K |
| Walleye Capital LLC | 0.00% | Reduce -7.0% | 15,229 | $58K |
| Deutsche Bank AG | 0.00% | New | 14,618 | $56K |
| Barclays PLC | 0.00% | Reduce -28.4% | 14,601 | $56K |
| Jane Street Group, LLC | 0.00% | Reduce -21.0% | 12,948 | $49K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -38.5% | 12,345 | $47K |
| Prelude Capital Management, LLC | 0.00% | Reduce -20.0% | 11,074 | $42K |
| UBS Group AG | 0.00% | Reduce -30.2% | 10,934 | $42K |
| FMR LLC | 0.00% | Reduce -17.1% | 9,575 | $36K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 8,135 | $31K |
| Corebridge Financial, Inc. | 0.00% | — | 7,092 | $27K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +111.0% | 7,064 | $27K |
| JPMorgan Chase & Co. | 0.00% | Reduce -6.2% | 5,860 | $22K |
| Wells Fargo & Company | 0.00% | Add +9.8% | 5,792 | $22K |
| Qube Research & Technologies Ltd | 0.00% | New | 3,126 | $12K |
| Citigroup Inc. | 0.00% | Add +7.3% | 3,014 | $11K |
| Royal Bank of Canada | 0.00% | Add +43.2% | 2,939 | $11K |
| Nisa Investment Advisors, LLC | 0.00% | New | 2,100 | $8K |
| Russell Investments Group, Ltd. | 0.00% | New | 1,481 | $6K |
| Legal & General Group Plc | 0.00% | No change | 962 | $4K |
| California State Teachers Retirement System | 0.00% | Reduce -36.2% | 955 | $4K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 819 | $3K |
| Amalgamated Bank | 0.00% | No change | 334 | $1K |
| PNC Financial Services Group, Inc. | 0.00% | New | 64 | $244 |
| HighMark Wealth Management LLC | 0.00% | No change | 50 | $191 |
| Arax Advisory Partners | 0.00% | New | 19 | $73 |
| Cwm, LLC | 0.00% | Add +1000.0% | 22 | $0 |
"% of holder's portfolio" is PRLD's weight in each manager's 13F, not the share of Prelude Therapeutics Inc. the manager owns.